戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 strates prior to large-scale production of a biological product.
2 and licensing biosimilar and interchangeable biological products.
3 nly used cell substrate in the production of biological products.
4 ropriate in the preparation of some types of biological products.
5 d structural differences between two or more biological products.
6 trate for the development and manufacture of biological products.
7 ication or formulation and eight vaccines or biological products.
8 Bioassays play central role in evaluation of biological products and those derived from bacterial tox
9  frugiperda, is used as a cell substrate for biological products, and no viruses have been reported i
10 g on reducing to practice a stable, reliable biological product as an alternative to electronic pacem
11 or use in the LPS detection in foodstuff and biological products, as well as bacteria identification,
12 boratory research animals and simian-derived biological products, could minimize human exposure to SF
13 tbreak threats, screening vaccines and other biological products for microbial contamination, and dis
14  a large increase in the number and types of biological products--from therapeutic antibodies to vacc
15 noclonal antibody development, as with other biological products, is understanding the properties of
16           Changes in production methods of a biological product may necessitate an assessment of comp
17 of an old debate on the safety assessment of biological products, namely whether the use of some type
18  process changes during the development of a biological product or post-approval.
19 annot be directly applied to the analysis of biological products or clinical samples without further
20 promised channels, easy-to-read barcoding of biological products, or provide a deterrent to counterfe
21 og (PTEN) is enhanced by the presence of its biological product, phosphatidylinositol 4,5-bisphosphat
22 s necessary to make a variety of competitive biological products regarding their equivalent products
23               Nuclear pharmacies that handle biological products should follow appropriate aseptic te

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。